Epstein–Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsinSeung Ju Kim, Woo Seob Kim, Jae‐Hun Kim et al.|Annals of Oncology|2015Cited by 69